Monte Carlo parametric study of stent impact on dose for catheter-based intravascular brachytherapy with 90Sr/90Y

Medical Physics

Volumn 31, Issue 7, 2004, Pages 1964-1971

  Ortego, Pedro M ^a   Prieto, Carlos ^b   Vano, Eliseo ^c  

^a Shielding Engineering and Analysis   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CATHETERS; MONTE CARLO METHODS; RADIOTHERAPY; STENTS; TISSUE;

ANALYTICAL EXPRESSIONS; DOSE DISTRIBUTIONS; GENERAL PERTURBATIONS; INTRAVASCULAR BRACHYTHERAPY; MATERIAL CHARACTERISTICS; MONTE CARLO CALCULATION; RADIATION TREATMENTS; SPATIAL ATTENUATIONS;

STRUTS;

STRONTIUM 90; YTTRIUM 90;

ALGORITHM; ARTICLE; BETA RADIATION; BRACHYTHERAPY; INTRAVASCULAR BRACHYTHERAPY; INTRAVASCULAR CATHETER; MONTE CARLO METHOD; PRIORITY JOURNAL; RADIATION DEPTH DOSE; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIOTHERAPY; STENT;

EID: 3142751126     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1753431     Document Type: Article

References (29)

1. D. R. Holmes, Jr., R. E. Vlietstra, H. C. Smith, G. W. Vetrovec, K. M. Kent, M. J. Cowley, D. P. Faxon, A. R. Gruentzig, S. F. Kelsey, and K. M. Detre, "Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PCTA Registry of the National Heart, Lung and Blood Institute," Am. J. Cardiol. 53, 77C-81C (1984).
2. P. W. Serruys, H. E. Luitjen, K. J. Beatt, R. Geuskens, P. J. de Feyter, M. van den Brand, J. H. Reiber, H. J. ten Katen, G. A. van Es, and P. G. Hugenholtz, "Incidence of restenosis after succesful coronary angioplasty: A time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3 and 4 months," Circulation 77, 361-371 (1988).
3. P. W. Serruys, P. de Jaegere, F. Kiemeneij, C. Macaya, W. Rutsch, G. Heyndrickx, H. M. Emanuelsson, J. Marco, V. Legrand, and P. Materne, "A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group," N. Engl. J. Med. 331, 489-495 (1994).
4. D. L. Fischman, M. B. Leon, D. S. Baim, R. A. Schatz, M. P. Savage, I. Penn, K. Detre, L. Veltri, D. Ricci, and M. Nobuyoshi, "A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators," N. Engl. J. Med. 331, 496-501 (1994).
5. K. W. Lau, Z. P. Ding, A. Johan, V. Kwok, and Y. L. Lim, "Angiographic restenosis rate in patients with chronic total occlusions and subtotal stenoses after initially successful intracoronary stent placement," Am. J. Cardiol. 83, 963-965, A9-A10 (1999).
6. C. Janicki, C. W. Coffey, D. M. Duggan, D. R. Fischel, and T. A. Fischell, "Radiation dose from a phosphorus-32 impregnated wire mesh vascular stent," Med. Phys. 24, 437-445 (1997).
7. R. Nath, H. Amols, C. Coffey, D. Duggan, S. Jani, Z. Li, M. Schell, C. Soares, J. Whiting, P. Cole, I. Crocker, and R. Schwartz, "Intravascular brachytherapy physics: Report of the AAPM Radiation Therapy Commitee Task Group No. 60," Med. Phys. 26, 119-152 (1999).
8. W. V. Prestwich, T. J. Kennett, and F. W. Kus, "The dose distribution produced by a P32-coated stent," Med. Phys. 22, 313-320 (1995).
9. F. A. Mourtada, C. G. Soares, S. M. Seltzer, and S. H. Lott, "Dosimetry characterization of P-32 catheter-based vascular brachytherapy source wire," Med. Phys. 27, 1770-1778 (2000).
10. Z. Xu, L. E. Reinstein, G. Yang, S. Pai, G. Gluckman, and P. R. Almond, "The investigation of P32 wire for catheter-based endovascular irradiation," Med. Phys. 24, 1788-1792 (1997).
11. N. Reynaert, F. Verhaegen, Y. Taeymans, M. van Eijkeren, and H. Thierens, "Monte Carlo calculations of dose distributions around P-32 and Au198 stent for intravascular brachytherapy," Med. Phys. 26, 1484-1491 (1999).
12. A. N. Li, N. L. Eigler, F. Litvack, and J. S. Whiting, "Characterization of a positron emitting V-48 nitinol stent for intracoronary brachytherapy," Med. Phys. 25, 20-28 (1998).
13. M. Sabaté, M. A. Costa, K. Kozuma, I. P. Kay, W. J. van der Giessen, V. L. M. A. Coen, J. M. R. Ligthart, P. Serrano, P. C. Levendag, and P. W. Serruys, "Geographical miss: A cause of treatment failure in radio-oncology applied to intracoronary radiation therapy," Circulation 101, 2467-71 (2000).
14. J. Asenjo, J. M. Fenández-Varea, and A. Sanchez-Reyes, "Characterization of a high-dose-rate Sr90/Y90 source for intravascular brachytherapy by using the Monte Carlo code PENELOPE," Phys. Med. Biol. 47, 697-711 (2000).
15. J. Sempau, E. Acosta, J. Baró, J. M. Fernández-Varea, and F. Salvat, "An algorithm for Monte Carlo simulation of coupled electron-photon transport," Nucl. Instrum. Methods Phys. Res. B 132, 377-390 (1997).
16. V. Sehgal, L. Zuofeng, and J. R. Palta, "Application of imaging-derived parameters to dosimetry of intravascular brachytherapy sources: Perturbation effects of residual plaque burden," Med. Phys. 29, 1580-1589 (2002).
17. V. Sehgal, I. Zuofeng, J. R. Palta, and W. E. Bolch, "Dosimetric effect of source centering and residual plaque for β-emitting catheter based intravascular brachytherapy sources," Med. Phys. 28, 2162-2171 (2001).
18. H. I. Amols, M. Zaider, J. Weinberger, R. Ennis, P. B. Schiff, and L. E. Reinstein, "Dosimetric considerations for catheter-based beta and gamma emitters in the therapy of neointimal hyperplasia in human coronary arteries," Int. J. Radiat. Oncol., Biol., Phys. 36, 913-921 (1996),
19. O. Chibani and X. A. Li, "Dosimetric effects of source-offset in intravascular brachytherapy," Med. Phys. 29, 530 (2002).
20. X. A. Li, "Dosimetric effects of contrast media for catheter-based intravascular brachytherapy," Med. Phys. 28, 757-763 (2001).
21. 90 intravascular brachytherapy sources used with balloon catheters," Med. Phys. 29, 1562-1571 (2002).
22. H. I. Amols, F. Trichter, and J. Weinberger, "Intracoronary radiation for prevention of restenosis. Dose perturbations caused by stents," Circulation 98, 2024-2029 (1998).
23. S. J. Ye, X. A. Li, J. R. Zimmer, J. C. Chu, and C. K. Choi, "Dosimetric perturbations of linear array of beta-emitter seeds and metallic stent in intravascular brachytherapy," Med. Phys. 27, 374-380 (2000).
24. X. A. Li, R. Wang, O. Yu, and M. Suntharalingam, "Beta versus gamma for catheter-based intravascular brachytherapy: Dosimetric perspectives in the presence of metallic stents and calcified plaques," Int. J. Radiat. Oncol., Biol., Phys. 46, 1043-1049 (2000).
25. P. Fan, S. T. Chiu-Tsao, N. S. Patel, A. Shih, K. Ravi, W. Sherman, H. S. Tsao, J. Pisch, and L. B. Harrison, "Effect of stent on radiation dosimetry in an in-stent restenosis model," Cardiovascular Rad. Med. 2, 18-25 (2000).
26. J. F. Briesmeister, "MCNP-a general Monte Carlo N-particle transport code," LANL, LA-12625-M Version 4B.
27. 9 ophtalmic applicators using Monte Carlo modeling," Med. Phys. 25, 29-36 (1998).
28. 90 and Ir192 SS sources for intravascular brachytherapy," Med. Phys. 27, 2528-2535 (2000).
29. X. A. Li, "Dose effects of stents in intravascular brachytherapy for instent restenosis: A Monte Carlo calculation," Int. J. Radiat. Oncol., Biol., Phys. 55, 842-848 (2003).